ARCHIVES

Wanted: Methods To Measure Or Estimate Renal Function For Dosing Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 36 No. 37 | October 15, 2010

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

July 27, 2007

NCI-Approved Trials Listed

March 30, 2007

Prime Contract Subcontract Opportunities

January 24, 1975

Conversation with The Cancer Letter: Pat White: NIH Funding “Our Only Concern”

September 26, 2014

Only Three Of 28 CCRU, CCSP Proposals Approved, But DRCCA Will Try Again, Board OKs New RFAs

May 13, 1983

Breast Cancer action Plan Calls For More federal Coordination, Patient Participation

March 23, 1994